A few studies report that the MPO-ANCA positivity rate in IPF and ILD patients is 4% and 15%, respectively, suggesting that MPO-ANCA positivity may represent a distinct subtype of IPF [43]. This evidence concerns the gene MPO and interstitial lung disease.